NLRP3 and metabolic dysfunction-associated steatohepatitis: Liver samples from patients with NASH showed significantly increased expression of the inflammosomal genes (NLRP3 and caspase-1) compared with normal liver tissue [133] or liver samples from patients with non-alcoholic fatty liver disease [134].